Scientists in western Turkey commenced the lab tests on Tuesday of an antigen they designed for a vaccine against the novel coronavirus.

Research is ongoing with the collaboration of the Ege University Drug Development and Pharmacokinetic Research Application Center (ARGEFAR) in Izmir province and the Scientific and Technological Research Council of Turkey (TUBITAK).

A total of 32 scientists specializing in different branches came together to conduct the studies.

Dr. Mert Doskaya told Anadolu Agency that the design of the antigen, which is the first phase of the vaccine effort, was completed in a week.

The Vaccine Research and Development

Read more: Turkey completes 1st phase of COVID-19 vaccine efforts